Global Acute Intermittent Porphyria Market Growth 2018-2023
Published On: October 2018
 
Report ID:351828
 
Category: Medical Devices
 
Pages: 133




Acute intermittent porphyria (AIP) is a genetic metabolic disorder affecting the production of heme, the oxygen-binding prosthetic group of hemoglobin. It is characterized by a deficiency of the enzyme porphobilinogen deaminase.

Over the next five years, LPI(LP Information) projects that Acute Intermittent Porphyria will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Acute Intermittent Porphyria market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Acute Intermittent Porphyria market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

Gonadotropin-Releasing Hormone Analogues

Prophylactic Hematin Infusions

Segmentation by application:

Hospitals & Clinics

Research Centers

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

Dahaner

Roche

Bio-Rad Laboratories

Siemens

ARKRAY

Sysmex Corporation

ACON Laboratories

...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Acute Intermittent Porphyria consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

To understand the structure of Acute Intermittent Porphyria market by identifying its various subsegments.

Focuses on the key global Acute Intermittent Porphyria manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Acute Intermittent Porphyria with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Acute Intermittent Porphyria submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Acute Intermittent Porphyria Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Acute Intermittent Porphyria Consumption 2013-2023

2.1.2 Acute Intermittent Porphyria Consumption CAGR by Region

2.2 Acute Intermittent Porphyria Segment by Type

2.2.1 Gonadotropin-Releasing Hormone Analogues

2.2.2 Prophylactic Hematin Infusions

2.3 Acute Intermittent Porphyria Consumption by Type

2.3.1 Global Acute Intermittent Porphyria Consumption Market Share by Type (2013-2018)

2.3.2 Global Acute Intermittent Porphyria Revenue and Market Share by Type (2013-2018)

2.3.3 Global Acute Intermittent Porphyria Sale Price by Type (2013-2018)

2.4 Acute Intermittent Porphyria Segment by Application

2.4.1 Hospitals & Clinics

2.4.2 Research Centers

2.5 Acute Intermittent Porphyria Consumption by Application

2.5.1 Global Acute Intermittent Porphyria Consumption Market Share by Application (2013-2018)

2.5.2 Global Acute Intermittent Porphyria Value and Market Share by Application (2013-2018)

2.5.3 Global Acute Intermittent Porphyria Sale Price by Application (2013-2018)

3 Global Acute Intermittent Porphyria by Players

3.1 Global Acute Intermittent Porphyria Sales Market Share by Players

3.1.1 Global Acute Intermittent Porphyria Sales by Players (2016-2018)

3.1.2 Global Acute Intermittent Porphyria Sales Market Share by Players (2016-2018)

3.2 Global Acute Intermittent Porphyria Revenue Market Share by Players

3.2.1 Global Acute Intermittent Porphyria Revenue by Players (2016-2018)

3.2.2 Global Acute Intermittent Porphyria Revenue Market Share by Players (2016-2018)

3.3 Global Acute Intermittent Porphyria Sale Price by Players

3.4 Global Acute Intermittent Porphyria Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Acute Intermittent Porphyria Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Acute Intermittent Porphyria Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Acute Intermittent Porphyria by Regions

4.1 Acute Intermittent Porphyria by Regions

4.1.1 Global Acute Intermittent Porphyria Consumption by Regions

4.1.2 Global Acute Intermittent Porphyria Value by Regions

4.2 Americas Acute Intermittent Porphyria Consumption Growth

4.3 APAC Acute Intermittent Porphyria Consumption Growth

4.4 Europe Acute Intermittent Porphyria Consumption Growth

4.5 Middle East & Africa Acute Intermittent Porphyria Consumption Growth

5 Americas

5.1 Americas Acute Intermittent Porphyria Consumption by Countries

5.1.1 Americas Acute Intermittent Porphyria Consumption by Countries (2013-2018)

5.1.2 Americas Acute Intermittent Porphyria Value by Countries (2013-2018)

5.2 Americas Acute Intermittent Porphyria Consumption by Type

5.3 Americas Acute Intermittent Porphyria Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Acute Intermittent Porphyria Consumption by Countries

6.1.1 APAC Acute Intermittent Porphyria Consumption by Countries (2013-2018)

6.1.2 APAC Acute Intermittent Porphyria Value by Countries (2013-2018)

6.2 APAC Acute Intermittent Porphyria Consumption by Type

6.3 APAC Acute Intermittent Porphyria Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Acute Intermittent Porphyria by Countries

7.1.1 Europe Acute Intermittent Porphyria Consumption by Countries (2013-2018)

7.1.2 Europe Acute Intermittent Porphyria Value by Countries (2013-2018)

7.2 Europe Acute Intermittent Porphyria Consumption by Type

7.3 Europe Acute Intermittent Porphyria Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Acute Intermittent Porphyria by Countries

8.1.1 Middle East & Africa Acute Intermittent Porphyria Consumption by Countries (2013-2018)

8.1.2 Middle East & Africa Acute Intermittent Porphyria Value by Countries (2013-2018)

8.2 Middle East & Africa Acute Intermittent Porphyria Consumption by Type

8.3 Middle East & Africa Acute Intermittent Porphyria Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.2 Acute Intermittent Porphyria Distributors

10.3 Acute Intermittent Porphyria Customer

11 Global Acute Intermittent Porphyria Market Forecast

11.1 Global Acute Intermittent Porphyria Consumption Forecast (2018-2023)

11.2 Global Acute Intermittent Porphyria Forecast by Regions

11.2.1 Global Acute Intermittent Porphyria Forecast by Regions (2018-2023)

11.2.2 Global Acute Intermittent Porphyria Value Forecast by Regions (2018-2023)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Acute Intermittent Porphyria Forecast by Type

11.8 Global Acute Intermittent Porphyria Forecast by Application

12 Key Players Analysis

12.1 Dahaner

12.1.1 Company Details

12.1.2 Acute Intermittent Porphyria Product Offered

12.1.3 Dahaner Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)

12.1.4 Main Business Overview

12.1.5 Dahaner News

12.2 Roche

12.2.1 Company Details

12.2.2 Acute Intermittent Porphyria Product Offered

12.2.3 Roche Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)

12.2.4 Main Business Overview

12.2.5 Roche News

12.3 Bio-Rad Laboratories

12.3.1 Company Details

12.3.2 Acute Intermittent Porphyria Product Offered

12.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)

12.3.4 Main Business Overview

12.3.5 Bio-Rad Laboratories News

12.4 Siemens

12.4.1 Company Details

12.4.2 Acute Intermittent Porphyria Product Offered

12.4.3 Siemens Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)

12.4.4 Main Business Overview

12.4.5 Siemens News

12.5 ARKRAY

12.5.1 Company Details

12.5.2 Acute Intermittent Porphyria Product Offered

12.5.3 ARKRAY Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)

12.5.4 Main Business Overview

12.5.5 ARKRAY News

12.6 Sysmex Corporation

12.6.1 Company Details

12.6.2 Acute Intermittent Porphyria Product Offered

12.6.3 Sysmex Corporation Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)

12.6.4 Main Business Overview

12.6.5 Sysmex Corporation News

12.7 ACON Laboratories

12.7.1 Company Details

12.7.2 Acute Intermittent Porphyria Product Offered

12.7.3 ACON Laboratories Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)

12.7.4 Main Business Overview

12.7.5 ACON Laboratories News

...

13 Research Findings and Conclusion




Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.